# IBM beats while the tech rally stalls — buy the quiet AI winner showing relative strength

_AI-generated trading idea · BULLISH · IBM, SPY_

> Canonical page: https://commonquant.ai/research/for-you/ibm-beats-while-the-tech-rally-stalls-buy-the-quiet-ai-winne--548ed110-7b4a-5077-8ecd-5487e81a2458

A company raising its full-year outlook is the clearest signal management can send that demand is real, and IBM's deal pipeline is easing rather than drying up. When a broad selloff drags down stocks with genuinely improving fundamentals, those names tend to snap back hardest once the panic fades. Buying a guidance-raising stock while everything around it is being sold offers an asymmetric setup: the bad news is the market's, not the company's.

## Idea

A company raising its full-year outlook is the clearest signal management can send that demand is real, and IBM's deal pipeline is easing rather than drying up. When a broad selloff drags down stocks with genuinely improving fundamentals, those names tend to snap back hardest once the panic fades. Buying a guidance-raising stock while everything around it is being sold offers an asymmetric setup: the bad news is the market's, not the company's.

## Advanced Analysis

### Verdict: IBM's improving fundamentals are real, but the setup says wait — RSI at 83.8 means buying at the exit signal

The thesis is interesting on a 3–12 month horizon: per Reuters on October 21, 2026, IBM raised its annual software outlook as deal delays eased, and Q2 2026 revenue rose 7.8% to $17.2B with net income up 78% to $2.2B — the strongest support for the "bad news is the market's, not the company's" claim. But we would not enter today: the strategy's exit condition is already live, with IBM's 14-day RSI at 83.8 versus the 65 threshold, and the entry requires a dip to or below the 200-day EMA at $252.47 that has not happened. The biggest risk is that the thesis's cash-quality pillar is unproven: free cash flow fell 52% quarter over quarter to $2.4B in Q2 2026, shares outstanding crept up to 942.1M, and provisional filings for the period ended September 30, 2026 show about $5.8M of net open-market insider selling. A decisive close below about $240, or continued weak cash conversion at Q3, would flip this from a wait to an avoid. Scope note: the paired rule-set's historical performance could not be measured because IBM's raw and adjusted prices use different bases, so no backtested edge can be cited. The verdict rests on fundamentals and live levels alone, and both argue for patience.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 58/100 |
| Trade readiness | 22/100 |
| Risk quality | 48/100 |
| Fundamentals trend | 62/100 |
| Score | 48/100 |
| Composite Score | 48/100 |
| Evidence Tier | not\_backtestable |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | not\_backtestable |

### Trade now

\*\*Wait — this setup's entry conditions are not live today.\*\* The business thesis is genuinely interesting: per the idea, IBM's full-year outlook raise and easing deal pipeline suggest the recent weakness is the market's, not the company's. But an attractive thesis is not the same as a met entry. On the daily chart as of the October 24, 2026 observation, IBM closed at $253.56 — about 1.1% \*above\* its 200-day EMA of $252.47 — so the required dip to or below that line has not occurred. More importantly, the momentum exit condition is already satisfied: IBM's 14-day RSI (a 0–100 momentum gauge) sits at 83.8, well above the 65 level this strategy treats as a signal to close a long. Buying here would mean entering at the exact reading the rules say to exit, with the fast stochastic at 92.4 versus its signal line at 84.4 — deep overbought territory, not a fresh crossover.

The pivotal condition is concrete: IBM needs to trade its low back at or below the 200-day EMA (currently $252.47, so a pullback of roughly 0.4% or more from $253.56) \*and then\* close back above it, with the 14-period stochastic crossing above its 3-period signal line from a lower level. Today the stochastic values are far above the signal line, so no fresh cross is in range. "Waiting" means letting price reset toward the $243.68 nearest support (about 4% below the last close) and letting RSI bleed out of overbought before the entry pattern can form. The downside that matters: a close below the second-ranked support (about $240) or an 8% unrealized loss would invalidate a position taken on a later, valid trigger.

One scope note: this rule-set's historical performance was not measured, because IBM's raw and adjusted prices use different bases, so no backtested edge can be cited here — the decision rests on the thesis and live levels only. That does not make the setup defective; it simply means waiting for the trigger is the only honest stance, and it is the right one anyway given the overbought reading.

\#\#\# Technical details
\- \*\*Entry (both IBM@1d and SPY@1d versions):\*\* (1) the day's low touches or falls below the 200-day EMA; (2) the close finishes back above it; (3) the 14-period stochastic %K crosses above its 3-period %D signal line. Current IBM: last close $253.56 vs. 200-day EMA $252.47 — price is above the line, so condition 1 is not met (distance $1.09); stochastic %K 92.4 vs. %D 84.4, no fresh cross. SPY: last close $761.37 vs. 200-day EMA $736.67 — 3.2% above the line; %K 24.8 vs. %D 30.1, so %K is below %D.
\- \*\*Exits:\*\* RSI (14) above 65 — IBM is already at 83.8 (met), SPY at 36.5 (far); or a 40-bar holding period. Take profit: close at or above the nearest resistance level (IBM $251.82 — note price already sits above it), or +15% unrealized gain. Stop loss: close below the second-ranked support (IBM about $240), or −8% unrealized loss.
\- \*\*Sizing method:\*\* fixed 2% risk with stops ranked off the second support, capped at 50% of the book.
\- Levels observed on the 1-day timeframe, data complete as of October 24, 2026, 18:45 UTC.

#### IBM price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | IBM |
| Timeframe | 1d |

#### SPY price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | SPY |
| Timeframe | 1d |

### IBM's Guidance Raise Is Backed by Real Numbers, Not Just Sentiment

The bull case is that IBM's improving demand story — a raised software outlook per the Reuters report of October 21, 2026 — sits on top…

#### IBM Gross margin

Gross margin trend from CommonQuant fundamentals/XBRL data; +13.1% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2007-12-31 | \0.42241815641892577% |
| 2012-03-31 | \0.4506140315324444% |
| 2012-06-30 | \0.47632160726059813% |
| 2012-09-30 | \0.4740776659797147% |
| 2012-12-31 | \0.48954060306783054% |
| 2012-12-31 | \0.5503957211521087% |
| 2013-03-31 | \0.45616883116883117% |
| 2013-06-30 | \0.48675974963890223% |
| 2013-09-30 | \0.48971634244579654% |
| 2013-12-31 | \0.49492207752599954% |
| 2013-12-31 | \0.5410720305652321% |
| 2014-03-31 | \0.47791869041194457% |
| Latest Value | \0.47791869041194457% |
| Change Pct | \13.13876620823493% |
| Ticker | IBM |
| Timeframe | reported periods |

#### IBM sector percentile check

Ranks IBM against 833 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Free cash flow | \98.91956782713085th percentile |
| Rnd Intensity | \31.805555555555554th percentile |
| Gross margin | \61.118012422360245th percentile |
| Revenue growth (YoY) | \58.843159065628484th percentile |
| Ticker | IBM |
| Sector | Information Technology |
| Peer Count | 833 |

### Scores

- **Conviction score breakdown:** 48
- **Thesis support:** 58
- **Trade readiness:** 22
- **Risk quality:** 48
- **Fundamentals trend:** 62

### Watch items

- **IBM — Price vs 200-day EMA**
- **IBM — Stochastic (14,3) vs signal (3,3)**
- **IBM — RSI (14)**
- **IBM — Close vs second-ranked support**
- **SPY — Price vs 200-day EMA**

## Key details

- Symbols: IBM, SPY
- Timeframes: 1d
- Tags: \#canonical-demand, \#cluster-version:1, \#direction:bullish, \#entity-kind:instrument, \#entity:IBM, \#entity:SPY, \#horizon:unspecified, \#intent:research, \#symbol:IBM, \#symbol:SPY

## Community

- Upvotes: 0
- Views: 0
- Copies: 0
- Cosigns: 0

## News sources

- [IBM raises annual software revenue outlook as deal delays ease](https://news.google.com/rss/articles/CBMipwFBVV95cUxNNXc4eW5mMHAyRUs0dWk0eVM3UkdXYW9GRUdXRzAtWXZjWFpqeGIzeC1vZUMzSGZETFFQRFdrWGFjTHQxMmFYdDN4VHlUb0hjTVlEdEN0NWEzT3ZCVlhzRmVNSlNTTWFMVGVKMG9rR0Z0d3ZUdnhQeUxadHdTcjRZTVhGRURsMlM1Q0hLXzAtMTRkdnVxRjdRUFJZbTl1YWxFRXU4blEyWQ?oc=5) — Reuters
- [CrowdStrike CEO's alarming prediction — plus, the sell-off spreads beyond tech](https://www.cnbc.com/investingclub/2026/10/23/crowdstrikes-alarming-prediction-plus-sell-off-spreads-beyond-tech.html) — CNBC

## Related

- [IBM trade ideas](https://commonquant.ai/markets/ibm)
- [SPY trade ideas](https://commonquant.ai/markets/spy)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.